FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/04/2026
Back to search
Official data from USPTO
PENZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PENZYME
ST13
US500000079411612Class
1, 3, 5
Filing
79411612
Registration
8112758
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/04/2026
Trademark type
Word
Nice classes
1, 3, 5
Filing date
10/17/2024
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Enzymatica AB (publ)
Representatives
Maurine Knutsson Knutsson IP AB
Technical classification
Nice Classes
Class 1Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
enzyme substratesother than for medical or veterinary purposes; activator enzymes for use in the manufacture of mouth spraysnose sprayspharmaceuticalsnutraceuticalsfoodcosmetic preparationscosmetic formulationsskin care preparationspharmaceutical preparationscreams and lotions for skin care and skin treatmentdental preparationsdentifriceshair care preparationssoapsbath saltscosmeticsessential oilsperfumesnatural cosmetics; enzyme stabilizers; enzymes for scientific purposes; enzymes for industrial purposes; enzyme preparations for industrial purposes; enzyme substrates for scientific purposes; purified enzymes for industrial use; enzymesother than for medical or veterinary use
Class 3
non-medicated skin care preparations; skin moisturizing gel and skin lotions; hair-care preparations; dentifricesdental care preparationsdental bleaching gels and creamsnon-medicated dental rinses; beautyskinbathbar soaps; perfumes; essential oils; cosmetics; natural cosmetics
Class 5
pharmaceutical preparations for skin care and wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating allergieshypertensionsunburnasthmahypoglycaemiadandruffchemical imbalancesdiabeteshalitosisskin disorders; pharmaceutical preparations for treatment and prevention of cardiovascularoncologicalpulmonarykidneyautoimmunemetabolicendocrinemusculoskeletalgenitourinaryneurologicalgastrointestinalhepatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of damaged skin and tissueacneinfectious diseasespaininflammationsepsisalopeciaobesitycognitive disorderssleep disorderspsychiatric diseases and disordersviral infections and diseasesbacterial infections and diseases; veterinary preparationsantioxidants and pain relief medication; veterinary preparations for treatment of intestinal bacteria; veterinary pharmaceutical preparations for treatment and prevention of cardiovascularoncologicalpulmonarykidneyautoimmunemetabolicendocrinemusculoskeletalgenitourinaryneurologicalgastrointestinalhepatological diseases and disorders; veterinary pharmaceutical preparations for the treatment and prevention of damaged skin and tissueacneinfectious diseasespaininflammationsepsisalopeciaobesitycognitive disorderssleep disorderspsychiatric diseases and disordersviral infections and diseasesbacterial infections and diseases; medical preparations for preventing or treating colds being viral infections and diseases; medical preparationsgel and lotions for skin treatment; medicated mouth care preparations; chewing gums for medical purposes; sanitary preparations for medical purposes; dietetic substances adapted for medical usenutraceuticals for treatment and prevention of cardiovascularoncologicalpulmonarykidneyautoimmunemetabolicendocrinemusculoskeletalgenitourinaryneurologicalgastrointestinalhepatological diseases and disorders; dietetic substances adapted for medical usenutraceuticals for the treatment and prevention of damaged skin and tissueacneinfectious diseasespaininflammationsepsisalopeciaobesitycognitive disorderssleep disorderspsychiatric diseases and disordersviral infections and diseasesbacterial infections and diseases; dietetic substances adapted for medical usenutraceuticals for use as a dietary supplement; dietetic supplementsbeveragesfoodssugarsugar substitutesconfectionaries adapted for medical purposes and medical use; dietetic preparations adapted for medical purposes; medicinal drinks; vitamin preparations and mineral supplements; medicated bath preparations and medicated bath salts; medical plasters; materials for dressingsbandages for dressingsburn dressingsfirst aid dressingsmedical dressingssterilized dressingswound dressings; anti-inflammatory sprays; disinfectants; fungicidesherbicides; enzymes and enzyme preparations for medical purposes
Publications
History of USPTO decisions and trademark events.
32 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/04/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/21/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/04/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/27/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
11/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
11/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2025
RFNT
REFUSAL PROCESSED BY IB
06/07/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/21/2025
RFRR
REFUSAL PROCESSED BY MPU
05/21/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/28/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/26/2025
CNRT
NON-FINAL ACTION WRITTEN
03/25/2025
DOCK
ASSIGNED TO EXAMINER
03/24/2025
MAFR
APPLICATION FILING RECEIPT MAILED
12/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2024
Continuous trademark protection
Get notified about every new filing that threatens PENZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.